GetTopicDetailResponse(id=1751448167b, topicName=婦科癌癥, introduction=婦科癌癥, content=null, image=null, comments=0, allHits=1426, url=https://h5.medsci.cn/topic?id=44816, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37145, tagList=[TagDto(tagId=37145, tagName=婦科癌癥)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2243822, encodeId=af79224382292, content=<a href='/topic/show?id=3b4765888dd' target=_blank style='color:#2F92EE;'>#液體活檢#</a> <a href='/topic/show?id=1751448167b' target=_blank style='color:#2F92EE;'>#婦科癌癥#</a>, objectTitle=追蹤婦科腫瘤 “蛛絲馬跡”：cfDNA/ctDNA 檢測(cè)在臨床決策中的大作用, objectType=article, longId=856120, objectId=3516856120c9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220409/1649505732114_5552845.jpg, objectUrl=/article/show_article.do?id=3516856120c9, replyNumber=0, likeNumber=55, createdTime=2024-12-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=3516856120c9, moduleTitle=追蹤婦科腫瘤 “蛛絲馬跡”：cfDNA/ctDNA 檢測(cè)在臨床決策中的大作用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3516856120c9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227430, encodeId=1255222e430f2, content=<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a> <a href='/topic/show?id=1751448167b' target=_blank style='color:#2F92EE;'>#婦科癌癥#</a>, objectTitle=溫灝教授：卵巢癌防篩治一體化——復(fù)旦腫瘤模式, objectType=article, longId=844601, objectId=49f984460134, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720670284984_5579292.jpg, objectUrl=/article/show_article.do?id=49f984460134, replyNumber=0, likeNumber=81, createdTime=2024-09-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=49f984460134, moduleTitle=溫灝教授：卵巢癌防篩治一體化——復(fù)旦腫瘤模式, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=49f984460134)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208437, encodeId=cc15220843ee0, content=<a href='/topic/show?id=1751448167b' target=_blank style='color:#2F92EE;'>#婦科癌癥#</a> <a href='/topic/show?id=4ad0142806f' target=_blank style='color:#2F92EE;'>#PIK3CA突變#</a> <a href='/topic/show?id=1de211522305' target=_blank style='color:#2F92EE;'>#阿培利司#</a>, objectTitle=阿培利司在PIK3CA突變晚期婦科癌癥中顯示出有前景的臨床活性, objectType=article, longId=828643, objectId=a9ff82864393, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240604/1717483954638_1608702.png, objectUrl=/article/show_article.do?id=a9ff82864393, replyNumber=0, likeNumber=107, createdTime=2024-06-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a9ff82864393, moduleTitle=阿培利司在PIK3CA突變晚期婦科癌癥中顯示出有前景的臨床活性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a9ff82864393)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205452, encodeId=4696220545257, content=<a href='/topic/show?id=78aa999190f' target=_blank style='color:#2F92EE;'>#靶向治療#</a> <a href='/topic/show?id=792b15145a6' target=_blank style='color:#2F92EE;'>#RAS突變#</a> <a href='/topic/show?id=1751448167b' target=_blank style='color:#2F92EE;'>#婦科癌癥#</a>, objectTitle=CCR：婦科癌癥也需重視RAS突變，指導(dǎo)靶向治療和評(píng)估預(yù)后, objectType=article, longId=826444, objectId=66588264448b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240518/1716043515216_5579292.jpg, objectUrl=/article/show_article.do?id=66588264448b, replyNumber=0, likeNumber=0, createdTime=2024-05-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=66588264448b, moduleTitle=CCR：婦科癌癥也需重視RAS突變，指導(dǎo)靶向治療和評(píng)估預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=66588264448b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199913, encodeId=98b0219991345, content=<a href='/topic/show?id=1751448167b' target=_blank style='color:#2F92EE;'>#婦科癌癥#</a>, objectTitle=婦科癌癥顱內(nèi)轉(zhuǎn)移總體生存的新評(píng)分工具, objectType=article, longId=822832, objectId=d836822832ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679868298385_4754896.png, objectUrl=/article/show_article.do?id=d836822832ec, replyNumber=0, likeNumber=86, createdTime=2024-04-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d836822832ec, moduleTitle=婦科癌癥顱內(nèi)轉(zhuǎn)移總體生存的新評(píng)分工具, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d836822832ec)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
